BE690635A - - Google Patents

Info

Publication number
BE690635A
BE690635A BE690635A BE690635A BE690635A BE 690635 A BE690635 A BE 690635A BE 690635 A BE690635 A BE 690635A BE 690635 A BE690635 A BE 690635A BE 690635 A BE690635 A BE 690635A
Authority
BE
Belgium
Prior art keywords
sep
product
drug
colloidal silica
inert support
Prior art date
Application number
BE690635A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE690635A publication Critical patent/BE690635A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE690635A 1965-12-03 1966-12-02 BE690635A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR40886A FR5080M (xx) 1965-12-03 1965-12-03

Publications (1)

Publication Number Publication Date
BE690635A true BE690635A (xx) 1967-06-02

Family

ID=8594338

Family Applications (1)

Application Number Title Priority Date Filing Date
BE690635A BE690635A (xx) 1965-12-03 1966-12-02

Country Status (4)

Country Link
BE (1) BE690635A (xx)
FR (1) FR5080M (xx)
LU (1) LU52489A1 (xx)
NL (1) NL6617036A (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468121A1 (fr) * 1989-07-13 1992-01-29 Philippe Perovitch Procédé de préparation galénique d'une composition thérapeutique notamment à base d'aspirine
US5683721A (en) * 1990-07-26 1997-11-04 Perovitch; Philippe Galenic preparation of therapeutic composition comprising aspirin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756992A (fr) * 1969-10-02 1971-03-16 Folch Vazquez Conrado Procede pour preparer des compositions de substances lipophilesa activite therapeutique

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468121A1 (fr) * 1989-07-13 1992-01-29 Philippe Perovitch Procédé de préparation galénique d'une composition thérapeutique notamment à base d'aspirine
WO1992001444A1 (fr) * 1989-07-13 1992-02-06 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
US5683721A (en) * 1990-07-26 1997-11-04 Perovitch; Philippe Galenic preparation of therapeutic composition comprising aspirin

Also Published As

Publication number Publication date
LU52489A1 (xx) 1967-02-02
NL6617036A (xx) 1967-06-05
FR5080M (xx) 1967-05-16

Similar Documents

Publication Publication Date Title
AU663249B2 (en) New crystalline form of a vitamin D analogue
EP0078785B1 (fr) Sels d'acide valproîque, leur préparation et leur utilisation
EP0233853B1 (fr) Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation
JPH09169757A (ja) Cdchの新規な結晶変態、その製造法及びこの変態を含む製薬学的調剤
JP2008542316A (ja) o−アセチルサリチル酸の塩基性アミノ酸との塩およびグリシンの安定な活性化合物複合体
US5191114A (en) Process for enhancing the flow characteristics of ibuprofen
CA2599637A1 (fr) Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
FR2547501A1 (fr) Excipient effervescent, sans alcalino-terreux, contenant des composes carbonates de l'arginine et un acide, et comprimes effervescents correspondants
BE690635A (xx)
EP0304424A1 (en) WATER SOLUBLE COMPLEX OF A POLY(VINYLPYRROLIDONE) COPOLYMER AND $g(a)-METHYL-(2-METHYLPROPYL)BENZENE ACETIC ACID
JP2000281561A (ja) 新規溶媒法固体分散体製剤
US5830509A (en) Microparticle complexes with 2-amino-1-phenylpropanol materials
US6696086B1 (en) Solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, and its preparation
JP3463813B2 (ja) マレイミド化合物の製造方法
US20100184744A1 (en) Method of preparing a pharmaceutical co-crystal composition
EP0116182B1 (fr) Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé
JPH01102021A (ja) 局所投与用効果持続性炎症抑制剤組成物
JP4467230B2 (ja) 有機物の造粒方法
EP0950050A1 (fr) Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
EP0662835A1 (fr) Nouvelles formulations pharmaceutiques de spiramycine.
FR1756M (xx)
FR2814679A1 (fr) Compositions pharmaceutiques dispersibles a base de cephalosporines, leur procede de preparation et leur utilisation
US4851543A (en) Water soluble multicomplex of aminobenzoic acid
BE892421A (fr) Compositions pharmaceutiques contenant de l'argentico-sulfadiazine comme substance active et procedes de preparation de ces compositions
JPH01213236A (ja) 包接化合物の製造方法